HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yann Duchartre Selected Research

Drug Therapy (Chemotherapy)

1/2017Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yann Duchartre Research Topics

Disease

2Hemolytic Anemia
11/2013 - 07/2012
2Erythropoietic Porphyria (Congenital Erythropoietic Porphyria)
11/2013 - 07/2012
1Leukemia
01/2017
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017
1Liver Diseases (Liver Disease)
07/2011
1Liver Cirrhosis (Hepatic Cirrhosis)
07/2011
1Liver Failure
07/2011
1Erythropoietic Protoporphyria
07/2011

Drug/Important Bio-Agent (IBA)

2PorphyrinsIBA
11/2013 - 07/2012
2Uroporphyrinogen III Synthetase (Uroporphyrinogen-III Synthase)IBA
11/2013 - 07/2012
1IntegrinsIBA
01/2017
1Antisense OligonucleotidesIBA
01/2017
1AntibodiesIBA
01/2017
1Proteasome InhibitorsIBA
11/2013
1Heme (Haem)IBA
07/2011
1Busulfan (Busulfex)FDA Link
07/2011
1protoporphyrin IXIBA
07/2011

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2017
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2011